Lacking reliable data on the stroke burden, a prospective, population-based study on stroke incidence and outcomes was carried out in Ulaanbaatar, Mongolia, from 2019 to 2021.
Between January 1, 2019, and December 31, 2020, all stroke cases in adult residents (aged 16 years) within Ulaanbaatar's six urban districts (population person-years, N=1,896,965) in Mongolia were identified using standardized diagnostic criteria through surveillance of multiple overlapping data sources—hospitalized, ambulatory, and deceased individuals. history of forensic medicine Data collection included details about social demographics, the patient's medical history, and management procedures. The incidence of first-ever stroke and its primary pathological types, both crude and standardized, was determined, and 95% confidence intervals were included in the reported results. Outcomes were characterized by 28-day case fatality ratios and the degree of functional recovery on the modified Rankin scale, assessed at 90 days and one year post-intervention.
3738 patients yielded 3803 stroke identifications; 2962 cases represented initial events (mean age 59 years [SD 13]; 1161 [392%] being female). The annual incidence rate of the first stroke, in its raw form, was 1561 per 100,000 (95% confidence interval 1505-1618). A further age-adjustment to the Mongolian population demonstrated a rate of 1716 (1575-1856). Finally, standardization against the world population resulted in an incidence of 1403 (1367-1439). The incidence of pathological stroke subtypes, adjusted for world factors, was 666 (95% confidence interval 648-683) for ischemic stroke, 545 (530-561) for intracerebral hemorrhage, and 187 (183-191) for subarachnoid hemorrhage. A higher incidence of ischaemic stroke and intracerebral haemorrhage was observed in men than in women, whereas subarachnoid haemorrhage risk remained comparable across different age groups; this consistent pattern was noteworthy. Risk factors such as hypertension (1363 cases, representing 631% of 2161), smoking (596 cases, comprising 268% of 2220), regular alcohol consumption (533 cases, accounting for 240% of 2220), obesity (342 cases, amounting to 161% of 2125), and diabetes (282 cases, totaling 127% of 2220), were found to be predominant. A scant 9% of acute ischemic stroke cases benefited from thrombolysis, largely owing to the prolonged timeframe between symptom onset and patient presentation to the hospital. The median delay was 160 hours, spanning an interquartile range of 30 to 480 hours. The overall case fatality rate over 28 days was 361% (95% CI 343-379), demonstrating substantial differences across stroke subtypes: ischaemic stroke (148%, 128-167), intracerebral haemorrhage (529%, 499-558), and subarachnoid haemorrhage (543%, 494-591). Concerning poor functional outcomes at one year, measured by mRS scores of 3-6 (implying death or dependence), the corresponding percentages were 616% (95% CI 598-634), 475% (447-503), 770% (745-795), and 618% (570-665), respectively.
Intracerebral and subarachnoid hemorrhages, forms of stroke, are prevalent amongst Ulaanbaatar's urban population in Mongolia. Tragically, half of patients die within the first month, and more than two-thirds are either deceased or permanently reliant on others for care within three months. While the general prevalence of stroke aligns with other nations, the average age of onset is 60, a full ten years ahead of the average in high-income countries. Epidemiological data provide a foundation for developing and expanding future stroke prevention programs, encompassing primary and secondary measures, as well as enhancing care system organization.
In conjunction, the Science and Technology Foundation of the Ministry of Education, Culture, and Science of Mongolia and The George Institute for Global Health.
The Science and Technology Foundation of the Mongolian Ministry of Education, Culture, and Science and The George Institute for Global Health.
The progressive trajectory of childhood-onset chronic kidney disease has a major and lasting impact on both projected life expectancy and the perceived quality of life. To determine the short-term risk of chronic kidney disease progression and identify children who might benefit from targeted nephroprotective therapies, we investigated the utility of urinary Dickkopf-related protein 3 (DKK3), a marker of kidney tubular cell stress.
This cohort study observed the association of urinary DKK3 with the combined renal endpoint (a 50% drop in estimated glomerular filtration rate [eGFR] or progression to end-stage renal disease) or kidney replacement therapy (dialysis or transplantation), as well as the interaction between this endpoint and intensive blood pressure control in the ESCAPE randomized controlled study. Furthermore, urinary DKK3 levels and eGFR values were determined in children aged 3 to 18 years with chronic kidney disease, who had urine samples available and were enrolled in the prospective, multi-center ESCAPE (NCT00221845, derivation cohort) and 4C (NCT01046448, validation cohort) studies, at both baseline and every six months during follow-up. The analyses underwent adjustments for age, sex, hypertension, systolic blood pressure SD score (SDS), BMI SDS, albuminuria, and eGFR.
In the analysis, a total of 659 children were involved, with 231 children originating from the ESCAPE study and 428 from the 4C study. The ESCAPE study contained 1173 half-year blocks, while 4C included 2762 such blocks. In the study cohorts, urinary DKK3 levels higher than the median (1689 pg/mg creatinine) were linked to a markedly greater 6-month decrease in eGFR than levels at or below the median (-56% [95% CI -86 to -27] vs 10% [-19 to 39], p<0.00001, in ESCAPE; -62% [-73 to -50] vs -15% [-29 to -01], p<0.00001, in 4C). The correlation held true, regardless of the participants' diagnoses, initial eGFR, or albuminuria. ESCAPE trial results revealed a restricted beneficial effect of tighter blood pressure control in children with urinary DKK3 concentrations greater than 1689 pg/mg creatinine, concerning both the composite kidney endpoint (HR 0.27 [95% CI 0.14 to 0.55], p=0.00003, number needed to treat 40 [95% CI 37 to 44] vs 2500 [669 to .]) and the requirement for renal replacement therapy (HR 0.33 [0.13 to 0.85], p=0.0021, number needed to treat 67 [61 to 72] vs 310 [274 to 359]). 4C study findings revealed that inhibiting the renin-angiotensin-aldosterone system led to a substantial drop in urinary DKK3 levels. Patients not taking angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers presented a least-squares mean of 12235 pg/mg creatinine (95% CI 10036 to 14433), while those on these inhibitors or blockers exhibited a significantly lower mean of 6861 pg/mg creatinine (5616 to 8106), demonstrating statistical significance (p<0.00001).
In children experiencing chronic kidney disease, the presence of DKK3 in their urine forecasts a short-term risk of reduced kidney function, and this biomarker can pave the way for a tailored approach to medical care by identifying patients who could benefit from targeted pharmacological nephroprotection, including escalated blood pressure reduction efforts.
None.
None.
Transgender women in sub-Saharan Africa face a high burden of HIV, yet, to our knowledge, no research study has compiled data across the complete HIV care continuum for this group within the region. To evaluate HIV prevalence and establish HIV care continuum indicators for transgender women, this study analyzed data from three South African metropolitan municipalities.
Data from a biobehavioral survey were obtained from transgender women who were sexually active in the metropolitan areas of Johannesburg, Buffalo City, and Cape Town, South Africa. Transgender women aged 18 and older, who had consensual sexual relationships with a man in the six months before the survey, were enrolled using the respondent-driven sampling (RDS) method. malignant disease and immunosuppression The study employed an interviewer-administered questionnaire to determine awareness of HIV status, while blood specimens collected from dried blood spots provided data on HIV antibodies, antiretroviral treatment (ART) exposure, and viral load suppression. Individualized RDS weights, calculated using RDS Analyst software, were employed to derive population-based estimates of HIV's 95-95-95 cascade indicators. Multivariate stepwise backward logistic regression analysis was employed to pinpoint the factors associated with each cascade indicator. A complete analysis included all eligible participants.
In the period from July 26, 2018, to March 15, 2019, 887 sexually active transgender women were enrolled in various locations, comprising 323 in Johannesburg, 305 in Buffalo City, and 259 in Cape Town. SB216763 clinical trial In Johannesburg, HIV prevalence was markedly elevated, with 229 (741%) of 309 tests revealing positive results (weighted prevalence estimate of 633%, 95% CI 555-705), followed by Buffalo City, where 121 (437%) of 277 tests exhibited positive outcomes (461%, 387-536), and finally Cape Town, where a positive result was observed in 122 (484%) of 252 tests (456%, 367-547). An estimated 542% (95% confidence interval: 458-624) of transgender women with HIV in Johannesburg reported awareness of their HIV status, while this rate was 242% (154-358) in Cape Town, and 395% (271-534) in Buffalo City. A substantial percentage of those in Johannesburg (821%, 733-885), Cape Town (782%, 579-903), and Buffalo City (647%, 452-802) who knew their HIV status were receiving ART. Viral suppression was observed in 344% (272-424) of individuals on ART in Johannesburg, 412% (307-526) in Cape Town, and a remarkable 550% (407-684) in Buffalo City.
To achieve viral load suppression in transgender women living with HIV, it is necessary to employ innovative strategies for both diagnosis and treatment. For South African transgender women, specifically those from racial groups other than Black South African, those with lower educational attainment, and those with limited outreach exposure, a robust HIV cascade requires innovative testing, adherence strategies, and differentiated service provision catered to their specific needs.
As part of the broader global effort, the US President's Emergency Plan for AIDS Relief and the US Centers for Disease Control and Prevention work hand in hand to combat the disease.